Friday, 18 September 2020

La Roche-Posay Changes The Face Of Acne With Latest FDA Approved Acne Ingredient

Link
Share
Class
Send
Send
  • PRN | 1 year ago

NEW YORK: La Roche-Posay is committed to improving access to dermatological care for people with acne, which affects over 50 million Americans.


La Roche-Posay announces the launch of Effaclar Adapalene Gel 0.1% Acne Treatment, containing adapalene, a prescription-strength retinoid acne treatment, now available over-the-counter.

La Roche-Posay is also launching My Skin Track PoreScan, their first skin analysis powered by artificial intelligence. La Roche-Posay is providing consumers new and innovative tools developed with dermatologists to address their skin concerns.

Over the past 3 decades, OTC (over-the-counter) acne treatments have been limited to only a handful of active ingredients, mostly with benzoyl peroxide and salicylic acid. These ingredients are widely used by consumers, as the vast majority of people with acne don't consult a dermatologist to get a prescription.

La Roche-Posay now offers a topical prescription-strength retinoid (adapalene) acne treatment in addition to its award-winning Effaclar Duo micronized benzoyl peroxide acne treatment. The American Academy of Dermatology (AAD) describes topical retinoids and benzoyl peroxide as first line treatments for mild to severe acne.

There are many effective acne prescriptions including combinations of benzoyl peroxide and topical retinoids. However, many don't have access to these prescriptions because they don't visit a dermatologist or their insurance won't cover it. OTC prescription-strength acne treatments are a game-changer for people who have limited access to a health care provider. It allows earlier access to treatment which can help prevent scarring. - Hilary Baldwin, MD, Board Certified Dermatologist

Along with skincare, La Roche-Posay believes better-looking skin starts with a personalized skin analysis and skincare regimen. Recognizing that many consumers are confused about which products are right for their skin type and concern, La Roche-Posay is launching My Skin Track PoreScan. This tool uses artificial intelligence to make personalized skincare recommendations for those concerned with clogged pores, raised imperfections, and residual marks

My Skin Track PoreScan not only provides consumers access to a personalized skincare regimen upon their initial skin analysis, but it also allows them to track changes in their skin after completing their regimen. This will provide insights into how to adapt their daily skincare routine with new product recommendations based on their new needs. - Adrien Dissous, VP of Maketing for La Roche-Posay USA

To create this innovative tool, La Roche-Posay partnered with dermatologists from around the world to analyze more than 6,000 images of men and women of multiple ethnicities, ages, and skin types. My Skin Track PoreScan was presented at the Worldwide Congress of Dermatology in June of 2019.

La Roche-Posay Effaclar Adapalene Gel 0.1% Acne Treatment will be available in stores and online for SRP $29.99 starting July 2019.
La Roche-Posay My Skin Track PoreScan will be available at porescan.com in July 2019 and through the YouCam makeup app.
La Roche-Posay Effaclar Duo Acne Treatment will have a reduced SRP of $29.99 from $36.95 effective 7/8/19.

La Roche-Posay Changes The Face Of Acne With Latest FDA Approved Acne Ingredient

Liked This Article? Be The First To Share it!
Share
Class
Send
Send


Find any Critical Errors? Please Report It!



You May Also Like: